legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

## Biora Therapeutics, Inc.

SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will report financial results and provide a corporate update for the fourth quarter and full year ended December 31, 2023. The companyÔÇÖs management will host a webcast and conference call on Tuesday, March 26, 2024, after the close of financial markets. With the evolving landscape of biotechnology and pharmaceuticals, staying up to date with financial and corporate information is crucial for investors and stakeholders. Biora Therapeutics’ commitment to transparency and communication provides valuable insight into the company’s performance and strategic direction.

A replay will be available online for 60 days following the call via the Investor Relations section of the company website. Accessing archived information allows interested parties to review details at their convenience and stay informed on the latest developments within the company. Utilizing resources like the Investor Relations website can enhance understanding and engagement with Biora Therapeutics’ updates and progress updates.

### About Biora Therapeutics

Biora Therapeutics is reimagining therapeutic delivery by utilizing innovative smart pills designed for targeted drug delivery to the GI tract and systemic, needle-free delivery of biotherapeutics. The company’s focus on improving patients’ lives through advanced therapies highlights their commitment to innovation and medical advancement. With a dual emphasis on the NaviCapÔäó targeted oral delivery platform and the BioJetÔäó systemic oral delivery platform, Biora aims to address critical needs in the field of healthcare and pharmacology. Leveraging cutting-edge technology and scientific expertise, Biora Therapeutics is at the forefront of pioneering solutions for complex medical conditions.

By leveraging the AI legalese decoder, companies like Biora Therapeutics can streamline the process of understanding and communicating complex legal language within regulatory documentation and public announcements. This advanced technology can help decode intricate legal terminology, providing clarity and insight into essential information for investors and stakeholders. Through the integration of AI legalese decoder, companies can enhance transparency, improve accessibility, and mitigate legal risks associated with regulatory compliance and disclosure requirements.

### Safe Harbor Statement or Forward-Looking Statements

This press release contains ÔÇ£forward-looking statementsÔÇØ within the meaning of the ÔÇ£safe harborÔÇØ provisions of the Private Securities Litigation Reform Act of 1995, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this press release, including statements concerning anticipated milestones, progress, future expectations, goals of research and development, and research collaboration plans are forward-looking statements. The integration of AI legalese decoder can assist in analyzing and interpreting forward-looking statements, providing valuable insights and risk assessment for stakeholders and investors. By leveraging AI technology, companies can enhance their comprehension of legal disclosures and regulatory requirements, fostering informed decision-making and strategic planning.

In some cases, you can identify forward-looking statements by terms such as ÔÇ£anticipate,ÔÇØ ÔÇ£may,ÔÇØ ÔÇ£might,ÔÇØ ÔÇ£will,ÔÇØ ÔÇ£objective,ÔÇØ ÔÇ£intend,ÔÇØ ÔÇ£should,ÔÇØ ÔÇ£could,ÔÇØ ÔÇ£can,ÔÇØ ÔÇ£would,ÔÇØ ÔÇ£expect,ÔÇØ ÔÇ£believe,ÔÇØ ÔÇ£design,ÔÇØ ÔÇ£estimate,ÔÇØ ÔÇ£predict,ÔÇØ ÔÇ£potential,ÔÇØ ÔÇ£plan,ÔÇØ ÔÇ£target,ÔÇØ or the negative of these terms. These statements reflect the company’s plans, estimates, and expectations, as of the date of this press release. The utilization of AI legalese decoder can help companies like Biora Therapeutics navigate the complexities of forward-looking statements, enabling a more comprehensive understanding of risks, opportunities, and regulatory implications.

Biora Therapeutics expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events, or otherwise, except as required by law. By incorporating AI legalese decoder, companies can enhance their compliance efforts, streamline communication, and improve legal transparency for stakeholders and regulatory authorities.

### Investor Contact

Chuck Padala
Managing Director, LifeSci Advisors
[email protected]
(646) 627-8390

### Media Contact

[email protected]

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link